Literature DB >> 25253568

Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.

R Tripathy1, A K Panda2, B K Das3.   

Abstract

INTRODUCTION: Ferritin is an acute-phase reactant that is elevated in various autoimmune disorders. Serum ferritin levels have been positively correlated with disease activity scores of rheumatoid arthritis and systemic lupus erythematosus (SLE). Further, enhanced levels of ferritin have also been reported in lupus nephritis. However, there are no reports from the Indian subcontinent.
METHODS: Seventy-six female SLE patients, diagnosed on the basis of revised ACR criteria, and 50 healthy females, age matched from similar geographical areas, were enrolled in the present study. Serum levels of ferritin, IFN-α and IL-6 were quantified by enzyme-linked immunosorbent assay (ELISA). Clinical, biochemical, serological and other markers of disease activity (C3, C4 and anti-dsDNA) were measured by standard laboratory procedure.
RESULTS: Serum ferritin levels were significantly higher in SLE patients compared to healthy controls (p < 0.0001). Ferritin levels positively correlated with SLE Disease Activity Index (SLEDAI) (p = 0.001, r = 0.35), anti-dsDNA (p = 0.001, r = 0.35), IFN-α (p < 0.0001, r = 0.51) and IL-6 (p < 0.0001, r = 0.65) and negatively correlated with C3 (p = 0.0006, r = -0.38) and C4 (p = 0.01, r = -0.28). Interestingly, serum levels of ferritin were positively associated with proteinuria (p = 0.001, r = 0.36), serum urea (p = 0.0004, r = 0.39) and serum creatinine (p = 0.0006, r = 0.38).
CONCLUSION: Serum ferritin is an excellent marker of disease activity and renal dysfunction in SLE.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  IFN-α; IL-6; SLEDAI; Systemic lupus erythematosus; biomarker; ferritin; lupus nephritis

Mesh:

Substances:

Year:  2014        PMID: 25253568     DOI: 10.1177/0961203314552290

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

1.  Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.

Authors:  R Naveen; Avinash Jain; Hafis Muhammed; Latika Gupta; Durga P Misra; Able Lawrence; Vikas Agarwal; Ramnath Misra; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2021-01-02       Impact factor: 2.631

2.  Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus.

Authors:  Nora Almutairi; Alwaleed Aljaser; Abdulaziz Almutairi; Manal Alshaikh; Abdelmoneim Eldali; Sulaiman M Al-Mayouf
Journal:  Int J Pediatr Adolesc Med       Date:  2019-07-17

3.  Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.

Authors:  Chi Chiu Mok; Hui Hua Ding; Marwa Kharboutli; Chandra Mohan
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-28       Impact factor: 4.794

4.  Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium.

Authors:  Samar A Soliman; Anam Haque; Sherene Mason; Larry A Greenbaum; M John Hicks; Chandra Mohan; Scott E Wenderfer
Journal:  Lupus       Date:  2021-05-14       Impact factor: 2.911

5.  Analysis of Antineutrophil Cytoplasm Antibody from 118 730 Patients in Tertiary Hospitals in Jiangxi Province, China.

Authors:  Liming Tan; Anjun Jiao; Juanjuan Chen; Xiaojing Feng; Liuyue Xu; Siqi He; Fuyan Tan; Yongqing Jiang; Heng Luo; Hua Li; Yang Wu; Yongjian Tian; Tingting Zeng; Jianlin Yu; Liping Cao; Jianfeng Zheng; Hui Xu; Ming Wei; Wen Gan; Weihua Peng; Yanming Liu; Jing Hou; Jiangxia Xu; LiHua Shuai; Wenzhi Huang; Junyun Huang; Yan Lin; Jianrong Liu
Journal:  Med Sci Monit       Date:  2017-09-07

Review 6.  Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.

Authors:  Norishi Ueda; Kazuya Takasawa
Journal:  Nutrients       Date:  2018-08-27       Impact factor: 5.717

Review 7.  Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendations.

Authors:  J J Ceron; L Pardo-Marin; M Caldin; T Furlanello; L Solano-Gallego; F Tecles; L Bernal; G Baneth; S Martinez-Subiela
Journal:  BMC Vet Res       Date:  2018-06-20       Impact factor: 2.741

Review 8.  Heme Catabolic Pathway in Inflammation and Immune Disorders.

Authors:  Bing Wu; Yanwei Wu; Wei Tang
Journal:  Front Pharmacol       Date:  2019-07-24       Impact factor: 5.810

Review 9.  The Role of Ferritin in Health and Disease: Recent Advances and Understandings.

Authors:  Nikhil Kumar Kotla; Priyata Dutta; Sanjana Parimi; Nupur K Das
Journal:  Metabolites       Date:  2022-06-30

10.  Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE).

Authors:  Robert Szulawski; Peter J Kourlas; Marc Antonchak
Journal:  Am J Case Rep       Date:  2018-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.